WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics ®, a clinical-stage biopharmaceutical company, today announced positive data from the STARLYNG-1 (LYN-005-C-301) study, comparing the ...
Biologics have long been defined by their processes, raising complicated questions about how to assess the effect of manufacturing changes on product quality 1 —i.e., whether pre- and post-change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback